Signaling an institutional-client-focused approach. — this is paired with applies its full assets to meet the needs of institutional stakeholders.
Ranked by shared stages, industries, geography, cheque size and investor type. 400 related investors in the directory.
Deliberate 60/40 tech/healthcare split dedicated to de novo company formation, with a transparent debate-driven partner scoring system (1–4) and proven multi-generation continuity. With a clear focus on healthcare innovation, the firm brings both capital and domain expertise.
Formative-stage investor oriented toward AI-driven health, mobility, fintech/insurtech and intelligent enterprise, delivering hands-on GTM and roadmap support from ex-corporate venture leaders and engineers leveraging Allianz's risk, data, and regulatory expertise. With a disciplined investment approach, the team drives value for both founders and investors.
Early-phase partner for founders building iconic, industry-transforming companies, demonstrated by two new funds totaling $347M. With a disciplined investment approach, the team drives value for both founders and investors.
Invests at the concept stage, co-founding and building breakthrough life sciences and deep-science platforms directly with university researchers, acting as a company-builder partner to commercialize frontier biology. With a disciplined investment approach, the team drives value for both founders and investors.
Digital security-focused, operator-led firm that co-founds and incubates formative-stage companies alongside world-class technologists, presenting hands-on founder support from leaders who've built flagship security companies.
Spearheaded by a former Google X founder, the firm brings a moonshot lab prototyping philosophy anchored in a structured Triad investment thesis encompassing deep technology, reimagined unit economics, and climate-positive outcomes. It stands out by offering hands-on prototyping assistance and reverse-engineering of unit-economics models for its portfolio.
